Research

KU Eye physicians performing cutting-edge, basic, clinical and applied

research in ophthalmology and vision science

Research

Faculty as Principle Investigator

INTACS Prescription Inserts For Keratoconus--Humanitarian Use Device

Principle Investigator: John Sutphin, MD


Faculty as Sub-Investigator

A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif®) in Patients with Relapsing Multiple Sclerosis - Not currently enrolling

Principle Investigator: Sharon Lynch, MD

Sub-investigator: Thomas Whittaker, MD


Multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy, safety, and tolerability of three doses of ACT-128800, an oral S1P1 receptor agonist, administered for twenty-four weeks in patients with relapsing-remitting multiple sclerosis

Principle Investigator: Sharon Lynch, MD

Sub-investigator: Thomas Whittaker, MD


A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 1.25 mg FTY720 Administered Orally Daily Versus Placebo in Patients with Primary Progressive Multiple Sclerosis

Principle Investigator: Sharon Lynch, MD

Sub-investigator: Thomas Whittaker, MD; Miranda Bishara, MD; Dirck Dekeyser, OD


IMGN853-0401 (First-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of IMGN853 in adults with ovarian cancer and other FOLR1-positive solid tumors (IMGN-0401))

Principle Investigator: KUMC Cancer Center

Sub-Investigators:  Miranda Bishara, MD; Paul Munden, MD and W. Abraham White, MD


A randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, efficacy and preliminary dose-response of BAF312 in patients with dermatomyositis

Principal Investigator:  Richard Barohn, MD

Sub-investigators:  Comprehensive Ophthalmologists


A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis

Principle Investigator: Sharon Lynch, MD

Sub-investigator: OCT exam by technicnians

Last modified: Aug 26, 2014
ID=x8292